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Campo et al. show that mosaic Myc over-
expression in cardiomyocytes leads to
the phenotypically silent replacement of
normal cardiomyocytes by the Myc-over-
expressing ones, through a process
known as cell competition. This work un-
covers a mechanism potentially relevant
to cardiac repair.
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Heterogeneous anabolic capacity in cell populations
can trigger a phenomenon known as cell competi-
tion, through which less active cells are eliminated.
Cell competition has been induced experimentally
in stem/precursor cell populations in insects and
mammals and takes place endogenously in early
mouse embryonic cells. Here, we show that cell
competition can be efficiently induced in mouse car-
diomyocytes by mosaic overexpression of Myc dur-
ing both gestation and adult life. The expansion of
the Myc-overexpressing cardiomyocyte population
is driven by the elimination of wild-type cardiomyo-
cytes. Importantly, this cardiomyocyte replacement
is phenotypically silent and does not affect heart
anatomy or function. These results show that the
capacity for cell competition in mammals is not
restricted to stem cell populations and suggest that
stimulated cell competition has potential as a cardio-
myocyte-replacement strategy.INTRODUCTION
Cell competition is a mechanism that eliminates suboptimal cells
from tissues when ‘‘fitter’’ cells are present (reviewed in Baker,
2011; de Beco et al., 2012; Levayer and Moreno, 2013; Vincent
et al., 2013). Cell-to-cell heterogeneity in anabolic capacity led
to the first description of cell competition, during Drosophila
development (Morata and Ripoll, 1975), and is currently the
most frequent feature found associated with this phenomenon.
The fluctuations in anabolic capacity that trigger cell competition
are within a physiological range, and ‘‘loser’’ cells are viable and
capable, in the absence of fitter cells, of sustaining tissue growth
and performance. Cell competition can thus be envisioned as an
optimization mechanism enabling tissues to achieve their best
possible cellular composition by favoring the fitter cell population
at the expense of less-fit cells. Cell competition can be experi-
mentally induced by generating loser cells through the mosaic
reduction of cell anabolism (Morata and Ripoll, 1975) or by
generating ‘‘winner’’ cells through the mosaic increase of cell
anabolism (supercompetition) (de la Cova et al., 2004; Moreno
and Basler, 2004). The conserved cell anabolism regulator MycCell Reis involved in cell growth and proliferation (reviewed in Dang,
2013; Gallant, 2013; Levens, 2013) and plays essential roles in
mammalian development (Davis et al., 1993; reviewed in Hurlin,
2013). Moderate increase in Myc levels in a mosaic fashion in
Drosophila imaginal discs (de la Cova et al., 2004; Moreno and
Basler, 2004) and pregastrulation mammalian embryos (Claverı´a
et al., 2013) induces supercompetition, leading to the phenotyp-
ically silent replacement of wild-type cells by Myc-overexpress-
ing cells without overt phenotypic consequences. In addition,
natural Myc fluctuations trigger cell competition in the mouse
epiblast (Claverı´a et al., 2013), indicating an endogenous role
for cell competition in optimization of the pool of precursor cells
that generate the embryo. Mosaic Myc overexpression also in-
duces cell supercompetition in embryonic stem cell cultures
(Claverı´a et al., 2013; Sancho et al., 2013), and hematopoietic
stem cells have been shown to undergo p53-dependent cell
competition (Bondar and Medzhitov, 2010; Marusyk et al.,
2010). These observations suggest that the capacity for cell
competitionmight be associatedwith stemness, but this hypoth-
esis has not been tested. Here, we explored this issue by asking
whether cell competition could be induced in one of the first lin-
eages to differentiate in the mammalian embryo, the cardiac
lineage.
Cardiac precursors originate early in gastrulation within the
anteriormost embryonic mesoderm (reviewed in Vincent and
Buckingham, 2010). During mouse gastrulation, cardiac precur-
sors migrate anteriorly and form a cardiac crescent, which by
embryonic day 8.0 (E8.0) has folded into a primary tube contain-
ing still-proliferative but differentiated and functionally active
cardiomyocytes (reviewed in Evans et al., 2010; Rana et al.,
2013). A subset of cardiac precursors remain undifferentiated
in the second heart field (Kelly et al., 2001) and are progressively
added to the heart tube until cardiac chambers and outflow and
inflow tracts are definitively laid down around E10. After birth,
most cardiomyocytes stop dividing and undergo hypertrophy
to establish the mature definitive myocardium (Soonpaa et al.,
1996). Here, we show that mosaic Myc overexpression in cardi-
omyocytes at levels that do not alter heart anatomy or function
promote the phenotypically silent replacement of wild-type
(WT) cardiomyocytes in the mouse fetal and adult myocardium
through cell competition. Our results show thewidespread ability
of mammalian cells to undergo Myc-driven cell competition and
identify cell competition as an efficient mechanism for phenotyp-
ically silent substitution of cell populations while preserving
organ function.ports 8, 1741–1751, September 25, 2014 ª2014 The Authors 1741
Figure 1. Mosaic Myc Overexpression
Driven by Nkx2.5Cre in the Developing
Heart
(A–C) Confocal sections showing EYFP+ car-
diomyocyte distribution and Myc expression by
immunofluorescence in the right ventricle of a
whole-mount Nkx2.5Cre-recombined iMOSWT
E10.5 heart (WT), as depicted in (G). (A0)–(C0) show
magnified details of the boxed areas in (A)–(C).
(D–F0) Similar data for the Nkx2.5Cre-recombined
iMOST1-Myc E10.5 heart (MYC). Scale bar, 50 mm.
Dashed lines in (B0) and (E0) outline the frontiers
between EYFP+ and EYFP cells. ECFP fluores-
cence is lost upon Myc immunodetection; how-
ever, all EYFP cells are ECFP+ (see Figure 2).
(G) Schematic representation of an E10.5 heart
identifying the area shown in A-F0. OFT, outflow
tract; RA, right atrium; LA, left atrium; RV, right
ventricle; LV, left ventricle.
(H) Graph showing the proportions observed of
EYFP and ECFP cardiomyocytes in Nkx2.5Cre-
recombined iMOSWT E10.5 whole hearts (n = 7).
Data are means ± SEM.
(I and J) Distribution of Myc protein levels in the
EYFP and ECFP cell populations of iMOSWT (I) and
iMOST1-Myc (J) mosaic whole hearts at E10.5; Myc
protein levels were quantified from the immuno-
fluorescence images similar to those in (A)–(F0). n =
425 cells in (I) and 449 in (J). Dashed vertical lines
indicate the mean for each distribution.RESULTS
Mosaic Myc Overexpression Induces Cardiomyocyte
Population Expansion in the Developing Heart
To test the consequences of overexpressing Myc in the devel-
oping heart, we used the recently established iMOS system
(Claverı´a et al., 2013), which allows the Cre-mediated condi-
tional induction of random genetic mosaics. We first generated
control random genetic mosaics in cardiac lineages using
Nkx2.5-Cre (Stanley et al., 2002) to induce the iMOSWT trans-
gene, which produces a random mosaic of enhanced yellow
fluorescent protein (EYFP) and enhanced cyan fluorescent pro-
tein (ECFP) WT cells. Quantitative confocal analysis of iMOSWT
recombination at E10.5 in iMOSWT; Nkx2.5-Cre hearts con-
firmed the mosaic expression pattern of the two reporter
proteins in embryonic cardiomyocytes at a reproducible cell
population ratio, as previously described (EYFP:ECFP = 3:1)
(Figures 1A–1C, 1G, and 1H). Again as described (Stanley
et al., 2002), the fluorescent protein distribution pattern indi-
cated iMOS activation throughout the embryonic heart (Figures
1A–1C0). We then generated Nkx2.5-Cre-induced iMOST1-Myc
mosaics, in which the EYFP cell population moderately overex-
presses Myc (Claverı´a et al., 2013) (Figures 1D–1F0). Confocal
analysis of EYFP simultaneously with MYC protein immunode-
tection showed the expected increase in MYC levels in the
EYFP cell population of iMOST1-Myc mosaics, but not iMOSWT
mosaics (Figures 1I and 1J). We then quantified the contribution
of the mosaic cell populations by confocal analysis at different
stages of heart development. In the iMOST1-Myc mosaics we
found a progressive reduction in the relative abundance of the1742 Cell Reports 8, 1741–1751, September 25, 2014 ª2014 The AuECFP-WT cell population—and a concomitantly increased rela-
tive abundance of the EYFP-Myc population— that was not
observed in the iMOSWT mosaics (Figures 2A–2G). The propor-
tion of ECFP cardiomyocytes at E9.5 in iMOST1-Mycmosaicswas
lower (but not significantly) than that observed in iMOSWT mo-
saics. From then on, the relative abundance of the ECFP-WT
population in iMOST1-Mycmosaics showed a progressive decline
to 60% of the iMOSWT value at E10.5, 40% at E11.5, and 25% at
postnatal day 0 (P0) (Figure 2G). The shift in cell populations thus
takes place mostly in a narrow time window between E9.5 and
E11.5.
Previous studies showed that Myc overexpression in cardio-
myocytes during fetal life can lead to pathological cardiac hyper-
plasia (Jackson et al., 1990). However, in these studies, Myc
expression was 20-fold above normal. To determine whether
the overexpression levels used here could lead to cardiac hyper-
plasia we characterized adult heart anatomy and cardiomyocyte
size. P0 hearts from Nkx2.5-Cre-recombined iMOST1-Myc and
iMOSWT mice were of normal size and anatomy (Figures S1A
and S1B and data not shown), and cardiomyocytes from the
iMOST1-Myc hearts were of a similar size to those from iMOSWT
hearts (Figure S1C).
The shift in the cell population proportion observed in iMOSWT
mosaics thus results from expansion of the EYFP Myc-overex-
pressing cardiomyocyte population and a concomitant reduc-
tion of the ECFP WT population relative contribution, without
disruption of heart cell composition or anatomy. These results
also indicate that the levels of Myc overexpression from the
iMOST1-Myc allele are within the limits that allow normal cardio-
myocyte development and do not provoke hyperplasia.thors
Figure 2. The Myc-Overexpressing Cardio-
myocyte Population Expands in the Devel-
oping Heart
(A–F) Confocal sections showing EYFP+ and
ECFP+ cardiomyocyte distributions in the left
ventricle of whole-mount E10.5 hearts from
Nkx2.5Cre-recombined iMOSWT (WT) (A–C) and
iMOST1-Myc (MYC) (D–F) embryos. Scale bar,
50 mm.
(G) Percentage ECFP+ area at different embryonic
stages in whole hearts of the iMOST1-Myc (MYC)
mosaics relative to that observed in the iMOSWT
(WT) mosaics, which was normalized to 100%.
Numbers on the x axis indicate the day of em-
bryonic development; P0 indicates postnatal day
0 (nR 5 embryos).
(H–J) Confocal detection of EYFP+ and ECFP+
cardiomyocyte distributions in histological sections
of the left ventricle of P0 hearts from Nkx2.5Cre-
recombined iMOSWT (WT) (H), iMOST1-Myc (MYC)
(I), and iMOST1-Myc/T2-p35 (MYC/p35) mice. Scale
bar, 50 mm.
(K–M) show masks of the EYFP detection in (H)
and (I).
(N) Percentage of ECFP+ cells observed at P0 in
whole hearts of the iMOST1-Myc (MYC) and iM-
OSWT (WT) mosaics relative to that observed in the
iMOSWT (WT) mosaics, which was normalized to
100%.
For ease of comparison, data for ECFP proportion
in MYC mosaics at P0 is repeated in (G) and (N).
nR 4). Data in (G) and (N) are means ± SEM; *p <
0.05; **p < 0.01; ***p < 0.001.Islet-1 Progenitors Are Highly Sensitive toMyc-Induced
Cell Competition
We next explored the impact of inducing Myc mosaicism in
Islet1+ cardiac progenitors. For this, we generated iMOST1-Myc
mosaics in second heart field (SHF) progenitors using Islet1-
Cre (Yang et al., 2006). This Cre driver provides partial inter-
spersed recombination of the SHF cell population, resulting in
about 7% EYFP recombined cardiomyocytes in the right
ventricle (RV) of iMOSWT mosaics (Figures 3A, 3D, 3E, and
3E0). In contrast, the RV of iMOS T1-Myc; Islet1-Cre hearts on
average contained 40% EYFP cardiomyocytes at P0, represent-
ing a 5.7-fold expansion during gestation of the original EYFP
cardiomyocyte population (Figures 3B, 3D, 3F, and 3F0). In addi-
tion, the ECFP cardiomyocyte population in the Islet-Cre-
induced iMOST1-Myc mosaic hearts was almost completely
eliminated by P0 (Figures 3E0, 3F0, and 3H). These results indi-
cate a more active elimination of the mosaic ECFP-WT cell pop-
ulation and a continued expansion of the Myc-overexpressing
cardiomyocyte population during fetal life, in a context in which
it is continuously confronted with WT cardiomyocytes. We thenCell Reports 8, 1741–1751, Sepcharacterized the temporal progression
of ECFP cardiomyocyte depletion in
iMOST1-Myc mosaics, finding that this
population was already reduced to 40%
of its original contribution by E9.5, with
further progressive reduction until thefinal residual presence at birth (Figures 3I–3L). The enhanced
early elimination of WT progenitors in the Islet-Cre-induced mo-
saics indicates that undifferentiated Islet1+ cardiac progenitors
are highly sensitive to Myc mosaicism.
The Myc-Overexpressing Cardiomyocyte Population
Expands by Apoptosis-Driven Cell Competition
To study the mechanisms underlying the expansion of the Myc-
overexpressing cardiomyocyte population during development,
we first determined the abundance of PHH3+ cells and bromo-
deoxyuridine (BrdU) incorporation in iMOS mosaics at E10.5,
when the shift in the cell population proportion is taking place.
Overall, PHH3+ and BrdU+ cell frequencies did not differ signifi-
cantly between iMOST1-Myc and iMOSWT cardiomyocytes (Fig-
ure S2). Moreover, the PHH3+ and BrdU+ cell frequencies in
the EYFP cell population of iMOST1-Myc mosaics was not
different from that in the ECFP population (Figures S2D and
S2E). These results fit with previous studies showing that the
Myc dosage induced by a single Rosa26 allele does not increase
proliferation rates in most tissues (Claverı´a et al., 2013; Murphytember 25, 2014 ª2014 The Authors 1743
Figure 3. Enhanced Expansion of Myc-
Overexpressing Cardiomyocytes upon
Mosaic Induction in Islet-1+ Progenitors
(A–G0 ) Confocal detection of EYFP+ (A–C), anti-
GFP immunofluorescence (detecting both EYFP
and ECFP) (E–G) and colocalization of both signals
(E0–G0) in histological sections from Islet1Cre-re-
combined iMOSWT (WT) (A, E, and E0), iMOST1-Myc
(MYC) (B, F, and F0), and iMOST1-Myc/T2-p35 (MYC/
p35) newborn mice. In (E0)–(G0), EYFP+ cells are
yellow because they are positive for both EYFP
and anti-GFP, and ECFP+ cells are detected in red,
as they are only positive for anti-GFP. Scale bar,
100 mm for (A)–(C) and 50 mm for (E0 ). RA, right
atrium; LA, left atrium; RV, right ventricle; LV, left
ventricle. (D) Percentage of the RV area positive
for anti-GFP immunofluorescence in Islet1Cre-
recombined iMOSWT (WT), iMOST1-Myc (MYC),
and iMOST1-Myc/T2-p35 (MYC/p35) newborn mice
(nR 4).
(H) Percentage of ECFP+ recombined area
with respect to the total EYFP+ECFP-recombined
area observed at P0 in the iMOST1-Myc (MYC) and
iMOST1-Myc/T2-p35 (MYC/p35) mosaics relative to
that observed in the iMOSWT (WT) mosaics, which
was normalized to 100% (nR 4).
(I–K) Confocal sections of the E9.5 (I) and E10.5 (J)
OFT and the E15.5 RV (K) from Islet1Cre-re-
combined iMOST1-Myc hearts, showing overlays of
EYFP and anti-GFP signals. Scale bar, 50 mm for I
and J and 100 mm for (K).
(L) Percentage of ECFP+ area with respect to the
total EYFP+ECFP-recombined area observed at
different stages in the iMOST1-Myc (MYC) mosaics
relative to that observed in the iMOSWT (WT) mo-
saics, which was normalized to 100%. Numbers
on the x axis indicate the day of embryonic
development; P0 indicates postnatal day 0 (nR 4).
For ease of comparison, data for ECFP proportion
in MYC mosaics at P0 are repeated in (H) and (L).
Data in (D), (H), and (L) are means ± SEM. *p <
0.05; **p < 0.01; ***p > 0.001.et al., 2008) and suggest that the shift in cardiomyocyte popula-
tions is not produced by overt differences in cell proliferation be-
tween the two cell populations.
To evaluate the role of cell death in the depletion of WT cardi-
omyocytes, we generated mosaics of the iMOST1-Myc/T2p35
strain, which produces a random mosaic of EYFP-Myc and
ECFP-p35 cells. p35 is a baculoviral caspase inhibitor able to
prevent apoptosis in insects and mammals (Claverı´a et al.,
1998; Hay et al., 1994). Quantitative confocal analysis of P0
hearts from iMOST1-Myc/T2p35 mosaics induced with either
Nkx2.5-Cre or Islet1-Cre showed that the p35-expressing
ECFP population was substantially, although not completely,
protected against elimination (Figures 2H–2N, 3C, and 3G–3H).
This result indicates that cell death is a predominant mechanism
in the population shift observed in iMOST1-Myc mosaics. How-
ever, expansion of the EYFP-Myc cell population did not differ
significantly between Islet1-Cre-induced iMOST1-Myc/T2p35 and
iMOS T1-Myc mosaics (Figure 3D), indicating that expansion of
Myc-enriched cardiomyocytes can progress through elimination
of nonrecombined WT cardiomyocytes even when small1744 Cell Reports 8, 1741–1751, September 25, 2014 ª2014 The Aunumbers of apoptosis-resistant ECFP-p35 cardiomyocytes are
present.
We next scored apoptosis by TUNEL at E10.5 in the Nkx2.5-
Cre-induced mosaics, concentrating on the outflow tract (OFT)
because this region had higher rates of apoptosis in the iMOSWT
mosaics. The iMOST1-Myc mosaics had a 5-fold higher overall
apoptosis rate than iMOSWT mosaics (Figures 4A–4C). Further-
more, the apoptosis rate in ECFP-WT cells of the iMOST1-Myc
mosaic was markedly higher than observed in the EYFP-Myc
cells (Figures 4D–4F). Interestingly, the apoptosis rate varied
between heart regions: whereas the ECFP/EYFP TUNEL ratio
was 4- to 5-fold above baseline in the ventricles, in the OFT it
was over 10-fold higher, indicating that ECFP-WT cardiomyo-
cytes in this region are especially sensitive to mosaic Myc
overexpression.
To study the range limit of the cellular interaction leading to
ECFP-WT cardiomyocyte apoptosis in iMOST1-Myc mosaics,
we took advantage of the Islet-Cre strain. The low-rate, inter-
spersed recombination induced by this line allowed us to score
apoptosis separately for WT cardiomyocytes in direct contactthors
Figure 4. Myc-Overexpressing Cardiomyo-
cytes Expand by Inducing Apoptosis of
Neighboring WT Cardiomyocytes
(A and B) Maximal projections of confocal stacks
(30 mm deep) from the OFT region of Nkx2.5Cre-
recombined iMOSWT (WT) (A) and iMOST1-Myc
(MYC) (B) whole-mount TUNEL-stained E10.5
hearts. Scale bar, 50 mm.
(C) TUNEL staining frequency in cardiomyocytes
from the mosaics shown in (A) and (B) (n = 4 WT
and 7 MYC mosaics).
(D and E) Confocal sections from the left ventricle
(LV) of Nkx2.5Cre-recombined iMOSWT (WT) (D)
and iMOST1-Myc (MYC) (E) whole-mount TUNEL-
stained E10.5 hearts, showing overlaid EYFP,
ECFP, and TUNEL signals. Filled arrowheads
point to EYFP+ TUNEL+ cells and empty arrow-
heads to ECFP+ TUNEL+ cells. Scale bar, 50 mm.
(F) ECFP/EYFP TUNEL frequency ratios in
different regions of Nkx2.5Cre-recombined iM-
OSWT (WT) and iMOST1-Myc (MYC) whole-mount
E10.5 hearts (n = 4 WT and 7 MYC mosaics). LV,
left ventricle; RV, right ventricle; OFT, outflow
tract. Arrowhead marks the unbiased ECFP/EYFP
TUNEL frequency ratio = 1.
(G) Maximal projection of the OFT from an Islet1-
MerCreMer-recombined iMOST1-Myc E10.5 heart
(MYC), showing overlaid EYFP, DAPI and TUNEL
signals. Scale bar, 70 mm.
(H) Computer 3D reconstruction of the stack
shown in (G).
(H0 ) Magnification of the boxed region in (H),
showing TUNEL+ WT cells contacting (red) and
not contacting (light blue, arrowhead) MYC-over-
expressing cells. Scale bar, 20 mm.
(I) TUNEL frequency inWT cells contacting and not
contacting EYFP cells in Islet1MerCreMer-re-
combined iMOST1-Myc E10.5 hearts (MYC) (N = 3
andR 2,815 cells).
Data in (C), (F), and (I) are means ± SEM. *p < 0.05;
**p < 0.01; ***p < 0.001.with EYFP cells and those not in contact (Figures 4G–4H0).
Apoptosis was 17-fold more frequent in WT cardiomyocytes in
direct contact with Myc-overexpressing EYFP cardiomyocytes
than in those not contacting EYFP cardiomyocytes (Figure 4I;
Movie S1).
These results indicate that the expansion ofMyc-overexpress-
ing cardiomyocytes requires the elimination of neighboring
WT cardiomyocytes through apoptosis triggered by direct cell-
cell contact or short-range signaling. Our characterization thus
establishes that the replacement of the WT cardiomyocyte
population by the Myc-overexpressing population is due to
apoptosis-driven cell competition.
MycOverexpression Induces Cardiomyocyte Population
Expansion in the Adult Heart
To determine whether increased Myc levels impact cardiomyo-
cyte population homeostasis during adult life, we inducedmosa-
icism in the adult cardiomyocyte population by using the tamox-
ifen-inducible aMHC-merCremer strain (Sohal et al., 2001)
(Figure 5A). Mosaics were induced by feeding animals tamoxifenCell Reduring the first month after weaning, and hearts were analyzed
immediately after tamoxifen cessation and at subsequent inter-
vals up to 1 year (Figure 5A). This protocol produced an initial
EYFP recombination slightly above 50% (Figure 6D). Previous
studies have shown that strong Myc overexpression in cardio-
myocytes of adult mice induces cardiomyocyte hypertrophy
(Xiao et al., 2001). We thus first analyzed whether hypertrophy
also resulted from long-term moderate Myc overexpression.
Tamoxifen-induced adult iMOST1-Myc and iMOSWTmice showed
no spontaneous cardiac malfunction and their hearts were of
normal size and anatomy even after 2 months of an intense exer-
cise protocol (Figures 5B–5E). Measurement of average cardio-
myocyte 2D size, both in histological sections and in cultures of
disaggregated cardiac cells (Figures 5F–5I), showed that cardio-
myocytes in iMOST1-Myc hearts were not only not bigger than
those in iMOSWT hearts but also in fact slightly smaller (Figure 5J).
Due to binucleation, adult cardiomyocytes could contain more
that one EYFP-Myc copy, and the levels of EYFP are expected
to correlate with theMyc dose in the iMOST1-Myc mosaics. Anal-
ysis of per-cell cardiomyocyte size and EYFP level showed noports 8, 1741–1751, September 25, 2014 ª2014 The Authors 1745
Figure 5. Mosaic MYC Overexpression in
Adult Cardiomyocytes Is Phenotypically
Silent
(A) aMHCmerCremer-recombined iMOST1-Myc
mosaics and control littermates were treated as
schematized for experiments in (B)–(L) and in
Figure 6.
(B) Long axis M-mode echocardiography image
from an iMOST1-Myc (MYC) mosaic WT littermate
at t2.
(C) Graphs show ejection fraction (EF) and left
ventricle (LV) mass from the echocardiographic
study in the iMOST1-Mycmosaics (MYC) and in WT
littermates (WT) at t3 (nR 3).
(D) EF and LVmass at t2 after a protocol of intense
exercise from t0 to t2 (see Experimental Pro-
cedures).
(E) Heart/body weight ratios in the iMOST1-Myc
mosaics (MYC) and in WT littermates (WT) at t3
(nR 3).
(F and G) Confocal sections showing wheat germ
agglutinin (WGA) staining to highlight cell perime-
ters in iMOSWT (WT) (F) and iMOST1-Myc (MYC) (G)
mosaics at t3. Scale bar, 50 mm.
(H and I) Bright-field confocal section of car-
diomyocytes isolated from iMOSWT (WT) (H) and
iMOST1-Myc (MYC) (I) mosaic hearts at t3. Scale
bar, 50 mm.
(J) Size (2D area) of cardiomyocytes shown in (H)
and (I). n R 4 hearts and 236 cells.*p < 0.1; **p <
0.05; ***p < 0.001. Horizontal bars represent mean
values.
(K and L) EYFP fluorescence intensity plotted
against cell size for cardiomyocytes isolated from
iMOSWT (WT) (K) and iMOST1-Myc (MYC) (L) mo-
saics. Lines in (K) and (L) represent the regression
line (R2 = 2.040 3 105 and 0.007204, respec-
tively).
Data in (C)–(E) are means ± SEM.correlation between these two parameters in either iMOSWT or
iMOST1-Myc mosaic hearts (Figures 5K and 5L). These results
show that sustained Myc overexpression from the iMOST1-Myc
allele during adult life does not provoke cardiomyocyte hypertro-
phy. Heart size and heart/body weight ratios were moreover
similar in both mosaics, indicating that overall cardiac cellular
and organ anatomy are preserved.
We next determined the proportions of cardiomyocyte popu-
lations at different times after mosaic induction. While in iMOSWT
hearts the proportion of EYFP cardiomyocytes was 53% at
1 year of age (Figures 6A and 6D), in the iMOST1-Myc mosaics,
the proportion increased progressively from a frequency similar
to that found in iMOSWT hearts to 66% at 1 year of age (Figures1746 Cell Reports 8, 1741–1751, September 25, 2014 ª2014 The Authors6B and 6D). Interestingly, half of this
enrichment took place during the first
month of observation. Since there were
no major changes in heart mass or cardi-
omyocyte size (Figures 5E and 5J), these
observations suggest that Myc-overex-
pressing cardiomyocytes expand at the
expense of WT cardiomyocytes duringadult life. To directly test this, we determined the relative fre-
quency of ECFP cardiomyocytes with respect to all fluorescent
(ECFP+EYFP) cardiomyocytes in 1-year-old iMOST1-Myc and
iMOSWT mosaics (Figures 6E–6H). The ECFP cell frequency
was 60% lower in the iMOST1-Myc mosaics, confirming that
the expansion of the Myc-overexpressing cardiomyocyte popu-
lation is concomitant with a reduction in theWT population. Most
adult cardiomyocytes in the mouse are tetraploid and contain
two nuclei (Soonpaa et al., 1996); this, together with the partial
recombination achieved by tamoxifen treatment, generates het-
erogeneous levels of EYFP-Myc content in cardiomyocytes, with
a predicted predominance of cardiomyocytes with one or two
active EYFP-Myc copies. We therefore refined our study to
Figure 6. Myc Overexpression Induces
Replacement of Adult Cardiomyocytes
(A–C) Confocal images of plated cardiomyo-
cytes isolated at t3 (12 months after tamoxifen
administration; see scheme in Figure 5) from
aMHCmerCremer-recombined iMOSWT (WT) (A),
iMOST1-Myc (MYC) (B), and iMOST1-Myc/T2-p35
(MYC/P35) (C) mosaics, showing native EYFP
expression and background autofluorescence.
(D) Percentage of EYFP+ cardiomyocytes in
cultures obtained from aMHCmerCremer-re-
combined iMOSWT (WT) hearts at t1 and t3 and
from iMOST1-Myc (MYC) hearts at t1-t3 (nR 3 and
300 cells). Data are means ± SEM.
(E–G) Confocal images of plated cardiomyocytes
obtained as in (A) –(C), showing anti-GFP immu-
nofluorescence, which identifies EYFP+ and
ECFP+ cardiomyocytes. Scale bar, 50 mm.
(H) Quantification of data represented in (A)–(G)
at t3. The graph on the left shows the absolute
frequencies of EYFP-Myc and ECFP-WT car-
diomyocytes in iMOSWT (WT), iMOST1-Myc
(MYC) and iMOST1-Myc/T2-p35 (MYC/P35) mo-
saics. In the graph on the right, the same data
were expressed as relative ECFP+/EYFP+ car-
diomyocyte proportions relative to that observed
in iMOSWT (WT) mosaics, which was normalized
to 100%.
(I) Graph represents the frequency of car-
diomyocytes according to EYFP intensity in
tamoxifen-induced aMHCmerCremer-recom-
bined iMOSWT (WT) and iMOST1-Myc (MYC) mo-
saics, measured in cardiomyocytes isolated at t3,
as in (A) –(C). The vertical dotted line marks the limit between background-fluorescent and EYFP-positive cardiomyocytes. Arrows indicate regions in which the
frequencies overtly differ between the two mosaics studied. Data in bar graphs are means ± SEM. *p < 0.05 **p < 0.01 ***p < 0.001.determine whether cardiomyocyte population expansion corre-
lated with EYFP-Myc levels. Fluorescence was measured in iso-
lated cardiomyocytes and the frequency of cells according to
fluorescence intensity was determined (Figure 6I). This analysis
showed that the enrichment in EYFP+ cardiomyocytes in
iMOST1-Myc mosaics mostly affects the populations with higher
EYFP levels at the expense of EYFP-negative cardiomyocytes,
whose frequency decreased (Figure 6I). These observations indi-
cate a correlation between Myc dose levels and cardiomyocyte
population prevalence in the adult myocardium.
Analysis of the Pathways Involved in Adult
Cardiomyocyte Competition
To identify the pathways altered in the iMOST1-Myc adult mosaic
heart, we performed a transcriptomic analysis by RNA se-
quencing (RNA-seq), comparing 8-week old iMOST1-Myc and
control hearts (Figure S3). Among the genes more significantly
up- or downregulated in iMOST1-Myc hearts, there is a strong rep-
resentation of genes involved in the response to cardiac over-
load, in cell growth/division, in energy metabolism, and in
apoptosis (Figure S3A). Gene set enrichment analysis on all
genes present in the RNA-seq experiment again detected the
protective response to cardiac overload in iMOST1-Myc hearts,
including the activation of the atrial natriuretic peptide and fetal
cardiomyocyte programs (Kishimoto et al., 2001; Kuhn et al.,
2002) and the hepatocyte growth factor (HGF)/Rho/tissueCell Reremodeling pathways (Madonna et al., 2012). In contrast, the
epidermal growth factor (EGF) pathway, involved in the develop-
ment of pathological hypertrophy (Shah and Catt, 2003), was
found repressed in iMOST1-Myc hearts. Regarding metabolic
processes, activation of the ribosome biosynthesis, a typical
response to Myc overexpression, was also detected. In parallel,
activation of the lysosomal pathway was as well present, indi-
cating that metabolic activity was globally increased including
both anabolic and catabolic processes. With regard to the meta-
bolic processes, iMOST1-Myc hearts showed a reduction in lipid
catabolism and in assembly of the peroxisome, the main organ-
elle for lipid catabolism, suggesting a modification in the fuel
usage by Myc-overexpressing cardiomyocytes. A remarkable
alteration was found in various regulators of the circadian
rhythm; Dbp and Per1, 2, and 3 were upregulated and Arntl
(Bmal1) was downregulated. Circadian rhythm transcription fac-
tors are essential regulators of cardiac metabolism and regulate
the balance between lipid and glucose usage in the heart and
display a feedback regulation with the oxidative phosphorylation
pathway in the heart (Durgan and Young, 2010). A major regu-
lator of cardiac metabolism, AMP-activated protein kinase, has
also been described to undergo circadian regulation (Tsai
et al., 2010), its regulatory subunit is overexpressed in the
iMOST1-Myc hearts, and it can be activated by Myc overexpres-
sion (Nieminen et al., 2013). The results observed are therefore
compatible with a modified metabolic status of the iMOST1-Mycports 8, 1741–1751, September 25, 2014 ª2014 The Authors 1747
Figure 7. Analysis of Autophagy and BrdU Incorporation in Post-
natal Hearts
(A) Confocal image of cardiomyocytes isolated from an iMOST1-Myc adult heart
showing GFP and BrdU staining. Arrowheads show BrdU+/GFP+ mono-
nucleated (empty arrowheads) and binucleated (filled arrowheads) car-
diomyocytes. Scale bar, 50 mm.
(B) Graph showing the frequency of BrdU+ cardiomyocytes in the ECFP-WT
(WT) and EYFP-Myc (MYC) populations of the iMOST1-Myc adult hearts. Bi,
binucleated; Mo, mononucleated.
(C) Graph showing the proportion of mononucleated cardiomyocytes within
the ECFP-WT (WT) and EYFP-Myc (MYC) populations of the iMOST1-Myc adult
hearts. n = 4 hearts and >300 cells/heart.
(D and E) Confocal sections showing postnatal hearts from iMOSWT (WT) (D)
and iMOST1-Myc (MYC) mosaics (E) showing Beclin-1 antibody staining
together with iMOS cell populations mapping. Scale bar, 50 mm. (D0 and E0)
Higher magnification of boxed areas in (D) and (E). Arrowheads point to Beclin+
cells. (D0 0 and E0 0) Beclin signal from (D0) and (E0) in isolation. Scale bar, 20 mm.
(F) Total Beclin+ cell frequency in iMOSWT (WT) and iMOST1-Myc (MYC)mosaics
(n = 3 WT and 5 MYC).
(G) Beclin+ cell frequency within the ECFP-WT (ECFP) and EYFP-Myc cell
populations (MYC) of the iMOST1-Myc mosaics.
Graphs in (C), (F), and (G) showmeans ± SEM. *p < 0.1; **p < 0.05; ***p < 0.001.
Statistical analysis in (B) was done using the c2 test. ns, not significant.with either a direct or indirect impact of Myc overexpression on
the circadian metabolic regulation. In agreement with this view,
the Ingenuity Pathway analysis on the selected up- and downre-
gulated genes (Figure S3B) indicates a modification of the lipid
metabolism and a reduction of the oxidative phosphorylation
activity in iMOST1-Myc hearts. The top networks identified by1748 Cell Reports 8, 1741–1751, September 25, 2014 ª2014 The Authis analysis for the upregulated, downregulated, and joint
gene sets are again the networks activated in response to car-
diac overload (Figures 3B and 3C). In agreement with these
results, we found that the expression of the atrial natriuretic pep-
tide was clearly activated in a patchy pattern in the ventricles of
the iMOST1-Myc mosaic hearts (Figure S3D).
Given the known functions of Myc in cardiomyocytes, the
pathways detected likely result from cell-autonomous Myc func-
tions and may relate to the ability of Myc-overexpressing cardi-
omyocytes to replace theWT cardiomyocyte population. In addi-
tion, the gene set enrichment study identified the activation of the
apoptosis regulation and inflammation pathways in iMOST1-Myc
hearts, which could be related to the death and removal of WT
cardiomyocytes. We therefore used the iMOST1-Myc/T2p35 mo-
saics to undertake a functional study of the involvement of cell
death. This analysis showed that p35 expression largely rescues
the ECFP cell population (Figures 6C, 6G, and 6H). These results
indicate that adult cardiomyocytes undergo Myc-induced cell
competition, which progresses by elimination of WT cardiomyo-
cytes and their replacement by cardiomyocytes with high Myc
levels. We then analyzed whether increased proliferation of the
Myc-overexpressing population is contributing to this phenome-
non. We found that BrdU incorporation was 4-fold more frequent
in the EYFP-Myc cardiomyocytes than in theWT cardiomyocytes
of iMOST1-Myc mosaic hearts (Figure 7B). This increase did not
alter the proportion of mononucleated cardiomyocytes (Fig-
ure 7C), suggesting that the balance between mononucleated
cardiomyocyte division and binucleation is preserved.
To directly assess the involvement of apoptosis in the cardio-
myocyte population shift, we analyzed the TUNEL pattern in
adult iMOST1-Myc mosaics; however, we found no significant dif-
ferences in TUNEL frequency between the EYFP-Myc and
ECFP-WT cell populations. These results suggested that, unlike
the situation during development, apoptosis might not be
involved in the elimination of WT cardiomyocytes in adults,
despite the activation of apoptotic pathways detected by RNA-
seq. We then explored whether alternative cell-death pathways
could be operating in postnatal cardiomyocytes. Given that
p35, in addition to inhibiting apoptotic cell death, can also inhibit
autophagic cell death (Martin and Baehrecke, 2004) and that
many apoptosis regulators are also involved in autophagic
cell death, we tested whether this pathway could be involved
in postnatal cardiomyocyte cell competition. Analysis of the au-
tophagic death-specific marker Beclin (Liang et al., 1999)
showed rare positive cells in iMOSWT hearts (Figures 7D–7D0 0);
however, the frequency of Beclin-positive cells increased by 5-
fold in iMOST1-Myc mosaic hearts (Figure 7E–7E0 0 and 7F). More-
over, the frequency of Beclin-positive cells within the iMOST1-Myc
mosaics was 9-fold higher in ECFP-WT cells than in EYFP-Myc
cells (Figure 7G). These results indicate that autophagic cell
death instead of apoptotic cell death is a major contributor to
postnatal cardiomyocyte cell competition.
DISCUSSION
In this study, we demonstrate the ability of moderate Myc over-
expression to induce cell competition in the developing and
adult mouse heart. Previous studies showed that strong Mycthors
overexpression during fetal life leads to cardiac hyperplasia due
to cardiomyocyte hyperproliferation, while overexpression in
adults leads to cardiac hypertrophy due to cardiomyocyte over-
growth (Jackson et al., 1990; Xiao et al., 2001). In contrast, we
found that the Myc overexpression levels provided by the
endogenous promoter of theRosa26 locus do not lead to cardiac
hypertrophy or hyperplasia. These results agree with previous
evidence of ubiquitous MycERT2 expression from the Rosa26 lo-
cus, which did not induce cardiac hypertrophy evenwhen two al-
leles were present (Murphy et al., 2008). A molecular signature
typical of the response to cardiac overload however was acti-
vated. The activated pathways (Nppa, HGF) are cardioprotective
and stimulate benign adaptation to increased cardiac function
demands (Kishimoto et al., 2001; Kuhn et al., 2002; Madonna
et al., 2012). In particular, the HGF pathway is not only involved
in the cardiac overload response but also stimulates cardiac
regeneration (Madonna et al., 2012). The activation of these
pathways in the absence of cardiac overload, or in the presence
of increased cardiac demand due to intense exercise, did not
result in functional impairment. In fact, the EGF pathway,
involved in pathological cardiac hypertrophy (Lee et al., 2011),
was found inhibited in the Myc mosaic hearts. The Myc levels
used here therefore can be considered ‘‘homeostatic’’ in the
heart, since hearts exposed to these levels stay within normal
anatomical and functional parameters. Interestingly, these
expression levels provided in a mosaic fashion are enough to
trigger cell competition, thereby enabling Myc-high cardiomyo-
cytes to eliminate neighboring WT cardiomyocytes and expand
to replace them. These results identify a window in which Myc
level fluctuations can affect cardiomyocyte behavior to promote
homeostatic changes in myocardial cell composition without
affecting organ development and function.
These observations highlight the remarkable ability of fetal
cardiomyocyte populations to undergo changes in composition
without disrupting cardiac function. Previous studies showed
that in mosaic hearts composed of wild-type cardiomyocytes
and others carrying a deleterious mutation, the wild-type cardio-
myocytes overproliferate during development to compensate for
the loss of mutant cardiomyocytes (Drenckhahn et al., 2008).
These studies indicate that the fetal heart bears sensing mecha-
nisms that detect the loss of functional cardiomyocytes and pro-
mote their replacement. Our present results show that this
replacement ability can also be stimulated by cell competition,
whereby even undamaged wild-type cardiomyocytes can be
eliminated and replaced by more competitive cells, without
compromising cardiac homeostasis. Interestingly, this ability is
retained during adult life, albeit at a notably slower pace with
respect to that observed during development. In Drosophila,
damaged postmitotic cells in the ovary can be eliminated and
compensated for by hypertrophy of the remaining healthy cells
(Tamori and Deng, 2013), while in the eye, postmitotic cells
become refractory to cell competition (Tyler et al., 2007). Here,
we found that, despite the predominant postmitotic nature of
adult cardiomyocytes, the loss of the outcompeted population
is not compensated by hypertrophy of winner cells but through
overproliferation.
The mechanisms by which neighboring cells compare their
fitness during cell competition in the mammalian embryo remainCell Reunknown, but a common theme of cell competition in the
epiblast and the developing heart is the elimination of loser cells
by apoptosis. In fact, in the fetal heart, we did not observe overt
differences in proliferation between the two mosaic populations.
This result is in apparent conflict with the fact that overexpansion
of Islet-Cre-recombined cardiomyocyte population requires
overproliferation and with the fact that the relative reduction of
the WT cardiomyocyte population in the Nkx2.5-Cre-recom-
bined mosaics requires compensatory proliferation to preserve
normal heart size. The 5.73 expansion of the IsletCre-recom-
bined population, however, involves only 2.5 extra cell cycles
per cell in the 11 days between the activation of the driver at
E7.5 and birth. This yields a total of 0.22 extra divisions per cell
and day. In the case of the studies with the Nkx2.5Cre driver, be-
tween E8.5 and E11.5, a 60% reduction in the original 25% WT
cardiomyocyte population was observed, which represents a
15% of the total cardiomyocyte population. To replace the
15% missing cardiomyocytes, only 0.15 extra cell divisions/car-
diomyocyte would be required during the 3-day observation
period. The degree of overproliferation required to explain the
changes observed is therefore small and might not be experi-
mentally detectable, especially since PHH3 and BrdU alone
might not be enough for a full characterization of the cell prolifer-
ation rate cell proliferation.
In adult cardiomyocytes, however, we found a clear increase
in the proliferative ability of winner cardiomyocytes, which likely
contributes to the replacement of the loser population. While this
increased proliferation capacity might be essential for the
competitive ability, it is clearly not sufficient, and elimination of
the loser population is still a requirement for cell competition in
the adult heart. In fact, this overproliferation is most likely only
compensatory for the loss of WT cardiomyocytes, since the ho-
mogeneous overexpression of two ROSA26-MycER copies
does not lead to overproliferation in the adult heart (Murphy
et al., 2008). The compensatory nature of this overproliferation
would also explain the absence of cardiac overgrowth upon
Myc mosaic overexpression.
These results suggest that fitness comparison between neigh-
bors and death of the less-fit cells is a common theme in cell
competition in very different scenarios. The fact that autophagic
instead of apoptotic cell death is observed in adult cardiomyo-
cytes could be more related to the specific features of adult car-
diomyocytes than to the cell-competition phenomenon. Dying
cells are normally eliminated by macrophages, but the size of
an adult cardiomyocyte is about 100 times that of amacrophage,
so a phase of self-destructive autophagy might be necessary
before they can be eliminated by macrophages in a controlled
manner. In fact, the typical example of autophagic death in
Drosophila involves as well the elimination of giant cells of the
salivary gland (Martin and Baehrecke, 2004). These consider-
ations are in agreement with the predominance of TUNEL-nega-
tive autophagic cardiomyocyte death reported in heart failure
patients (Knaapen et al., 2001).
The fact that cardiomyocytes undergo Myc-induced cell
competition suggests that cell competition operates during
normal heart development for the elimination of impaired cardi-
omyocytes unable to meet the anabolic rates demanded in the
myocardium. Anabolism-induced cell competition thus appearsports 8, 1741–1751, September 25, 2014 ª2014 The Authors 1749
as a widespread phenomenon in mammalian tissues and not
restricted to stem cell pools like the epiblast. There is an impor-
tant difference, however, between endogenous cell competition
in the epiblast and how it might operate during cardiogenesis:
whereas epiblast development is characterized by a strong
pattern of cell competition-associated apoptosis, during cardio-
genesis, cardiomyocyte death is very infrequent (Poelmann
et al., 2000). This suggests that while cell competition would
work as a cell quality-control mechanism in both scenarios, in
the epiblast it functions as a constitutive program, whereas
during cardiogenesis it is used contingently, only if impaired car-
diomyocytes appear. Since cardiomyocyte competition ability
extends into adult life, it will be very interesting in the future to
study whether cell competition is involved in maintaining tissue
fitness during aging and whether it can contribute to natural or
induced repair of cardiac insults in which cardiomyocytes are
lost or impaired.
EXPERIMENTAL PROCEDURES
Mouse Strains
The iMOSWT, iMOST1-Myc, and iMOST1-Myc/T2-p35 mouse lines have been
described (Claverı´a et al., 2013). Here, they were used in combination with
different Cre-expressing lines to induce genetic mosaics in the developing
and adult mouse heart. Experimental embryos or born mice were generated
from crosses of homozygous iMOS females with males carrying the different
Cre drivers: Nkx2.5Cre (Stanley et al., 2002), Islet1Cre (Yang et al., 2006),
and aMHCmerCremer (Sohal et al., 2001). Mice were genotyped by PCR
(Claverı´a et al., 2013). To induce recombination in iMOS;aMHCmerCremer
mice, they were fed for 1 month with pellets containing tamoxifen at 40 g/kg
(Teklad ref. TD.07262).
Confocal Microscopy
Whole embryonic hearts or histological sections were imaged with a Nikon
A1R confocal microscope using 405, 458, 488, 568, and 633 nm wavelengths
and 203/0.75 dry and 403/1.30 oil objectives. Areas occupied by EYFP and
ECFP cells were quantified using the threshold detection and particle analysis
tools in ImageJ (NIH; http://rsb.info.nih.gov/ij). To calculate the relative fre-
quency of ECFP cells, the percentage of ECFP area observed was divided
by the average percentage in iMOSWT mosaics. All percentages were normal-
ized to a 100% value in theWTmosaic. ECFPwas scored either by direct iden-
tification of native ECFP fluorescence or by subtracting the area of native EYFP
from the anti-GFP staining, which detects both EYFP and ECFP.
Immunofluorescence and TUNEL Assay
Embryos were obtained at different days of gestation and fixed overnight at
4C in 2% paraformaldehyde in PBS. Hearts were either dissected for
whole-mount staining or gelatin embedded and cryosectioned. Adult cardio-
myocytes were isolated by Langerdorff perfusion with liberase (Roche Applied
Science) and plated for confocal imaging as described previously (Garcı´a-
Prieto et al., 2014). Primary antibodies used were anti-phosphohistone H3
(Ser 10), anti-Myc polyclonal antibody (Millipore), Living colors Rabbit poly-
clonal anti-GFP antibody (Clontech), Beclin1 (Cell Signaling), and Nppa (Milli-
pore). Immunofluorescence was performed following standard procedures.
TUNEL was performed on whole-mount embryonic hearts or sections using
terminal deoxynucleotidyl transferase (TdT) and biotin-16-20-deoxy-uridine-
50-triphosphate (Biotin-16-dUTP) (both from Roche), and developed with
various streptavidin fluorescent conjugates (Jackson ImmunoResearch).
Statistical Analysis
To compare average percentages of ECFP cells/area between more than two
groups, the Kruskal-Wallis test was used (assuming nonnormal distributions).
For comparisons of two groups, a Mann-Whitney test was used. To test the
correlation between cell size and EYFP expression, a linear regression model1750 Cell Reports 8, 1741–1751, September 25, 2014 ª2014 The Auwas used. All comparisons were made using Prism statistical analysis soft-
ware. The significance of BrdU+ frequency andmononucleated cardiomyocyte
frequency comparisons from adult hearts was analyzed using a proportions
test as implemented in R.
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